These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 37332582)
1. Biology of mitral valve prolapse: from general mechanisms to advanced molecular patterns-a narrative review. Ronco D; Buttiglione G; Garatti A; Parolari A Front Cardiovasc Med; 2023; 10():1128195. PubMed ID: 37332582 [TBL] [Abstract][Full Text] [Related]
2. Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition. Morningstar JE; Nieman A; Wang C; Beck T; Harvey A; Norris RA J Am Heart Assoc; 2021 Jul; 10(13):e020919. PubMed ID: 34155898 [TBL] [Abstract][Full Text] [Related]
3. Genetics of syndromic and non-syndromic mitral valve prolapse. Le Tourneau T; Mérot J; Rimbert A; Le Scouarnec S; Probst V; Le Marec H; Levine RA; Schott JJ Heart; 2018 Jun; 104(12):978-984. PubMed ID: 29352010 [TBL] [Abstract][Full Text] [Related]
4. Genetics and pathophysiology of mitral valve prolapse. Delwarde C; Capoulade R; Mérot J; Le Scouarnec S; Bouatia-Naji N; Yu M; Huttin O; Selton-Suty C; Sellal JM; Piriou N; Schott JJ; Dina C; Le Tourneau T Front Cardiovasc Med; 2023; 10():1077788. PubMed ID: 36873395 [TBL] [Abstract][Full Text] [Related]
5. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation. Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615 [TBL] [Abstract][Full Text] [Related]
6. The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration. Tang Q; McNair AJ; Phadwal K; Macrae VE; Corcoran BM Front Cardiovasc Med; 2022; 9():872288. PubMed ID: 35656405 [TBL] [Abstract][Full Text] [Related]
7. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers. Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982 [TBL] [Abstract][Full Text] [Related]
8. Biology of mitral valve prolapse: the harvest is big, but the workers are few. Loardi C; Alamanni F; Trezzi M; Kassem S; Cavallotti L; Tremoli E; Pacini D; Parolari A Int J Cardiol; 2011 Sep; 151(2):129-35. PubMed ID: 21168228 [TBL] [Abstract][Full Text] [Related]
14. A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse. Ibarrola J; Garcia-Peña A; Matilla L; Bonnard B; Sádaba R; Arrieta V; Alvarez V; Fernández-Celis A; Gainza A; Navarro A; Alvarez de la Rosa D; Rossignol P; Jaisser F; López-Andrés N Circ Res; 2020 Jul; 127(3):e80-e93. PubMed ID: 32329663 [TBL] [Abstract][Full Text] [Related]
15. Sudden Cardiac Arrest as first Manifestation of Malignant Mitral Valve Prolapse in a Young Patient: A Case Report and Review of the Literature. Bigdelu L; Bitar Z; Maadarani O Eur J Case Rep Intern Med; 2024; 11(5):004505. PubMed ID: 38715888 [TBL] [Abstract][Full Text] [Related]
16. P210Long- term outcome of primary mitral valve prolapse: results from a population of 250 patients referred to a tertiary cardiovascular center. Mecarocci V; Mori F Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(suppl_2):ii29-ii37. PubMed ID: 28415082 [TBL] [Abstract][Full Text] [Related]
17. Floppy mitral valve/mitral valve prolapse syndrome: Beta-adrenergic receptor polymorphism may contribute to the pathogenesis of symptoms. Theofilogiannakos EK; Boudoulas KD; Gawronski BE; Langaee TY; Dardas PS; Ninios V; Kelpis TG; Johnson JA; Pitsis AA; Boudoulas H J Cardiol; 2015 May; 65(5):434-8. PubMed ID: 25172623 [TBL] [Abstract][Full Text] [Related]
18. The genetics of mitral valve prolapse. Grau JB; Pirelli L; Yu PJ; Galloway AC; Ostrer H Clin Genet; 2007 Oct; 72(4):288-95. PubMed ID: 17850623 [TBL] [Abstract][Full Text] [Related]